These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 3857768)
21. Demographic characteristics, patterns and risk factors for retinal vein occlusion in Nepal: a hospital-based case-control study. Thapa R; Paudyal G; Bernstein PS Clin Exp Ophthalmol; 2010 Aug; 38(6):583-90. PubMed ID: 20584017 [TBL] [Abstract][Full Text] [Related]
22. [Retinal venous obliteration and general pathology]. Aconiu M; Mihălaş G; Nemoianu C Oftalmologia; 1992; 36(1):39-45. PubMed ID: 1520668 [TBL] [Abstract][Full Text] [Related]
23. High prevalence of resistance to APC in young patients with retinal vein occlusion. Kuhli C; Hattenbach LO; Scharrer I; Koch F; Ohrloff C Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):163-8. PubMed ID: 11935272 [TBL] [Abstract][Full Text] [Related]
24. Young patients with branch retinal vein occlusion: a review of 60 cases. Lam HD; Lahey JM; Kearney JJ; Ng RR; Lehmer JM; Tanaka SC Retina; 2010 Oct; 30(9):1520-3. PubMed ID: 20924266 [TBL] [Abstract][Full Text] [Related]
25. [The study of clinical characteristic of nonischemic central retinal vein occlusion]. Wang GL; Zhang F; Peng XY; Meng SM Zhonghua Yan Ke Za Zhi; 2008 Feb; 44(2):152-6. PubMed ID: 18683702 [TBL] [Abstract][Full Text] [Related]
26. Association of systemic diseases with retinal vein occlusive disease. Shrestha RK; Shrestha JK; Koirala S; Shah DN JNMA J Nepal Med Assoc; 2006; 45(162):244-8. PubMed ID: 17189969 [TBL] [Abstract][Full Text] [Related]
27. Retinal vein occlusion: C-reactive protein and arterial hypertension. Dodson PM; Shine B Acta Ophthalmol (Copenh); 1984 Feb; 62(1):123-30. PubMed ID: 6720266 [TBL] [Abstract][Full Text] [Related]
29. Central retinal vein occlusion in young women: rare cases with oral contraceptive pills as a risk factor. Thapa R; Paudyal G Nepal Med Coll J; 2009 Sep; 11(3):209-11. PubMed ID: 20334075 [TBL] [Abstract][Full Text] [Related]
30. The influence of ticlopidine on the natural course of retinal vein occlusion. Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648 [TBL] [Abstract][Full Text] [Related]
34. [Prevalence of sleep-disordered breathing in patients with retinal vein occlusion]. Kanai H; Shiba T; Hori Y; Saishin Y; Maeno T; Takahashi M Nippon Ganka Gakkai Zasshi; 2012 Feb; 116(2):81-5. PubMed ID: 22509695 [TBL] [Abstract][Full Text] [Related]
35. Treatment of the occlusion of the central retinal vein by section of the posterior ring. Arciniegas A Ann Ophthalmol; 1984 Nov; 16(11):1081-6. PubMed ID: 6517441 [TBL] [Abstract][Full Text] [Related]
36. Retinal vein occlusion and traditional risk factors for atherosclerosis. O'Mahoney PR; Wong DT; Ray JG Arch Ophthalmol; 2008 May; 126(5):692-9. PubMed ID: 18474782 [TBL] [Abstract][Full Text] [Related]
39. [Considerations on occlusion of the central retinal vein]. Segal N; Spineanu L Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1983; 27(4):251-5. PubMed ID: 6229817 [No Abstract] [Full Text] [Related]
40. Mechanisms leading to an acute rise in intraocular pressure in retinal vein occlusion. Ansons AM; Clearkin L; Bryce I Eye (Lond); 1990; 4 ( Pt 3)():439-44. PubMed ID: 2209906 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]